Related Experiment Video
Updated: Jul 13, 2026

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
Published on: March 24, 2015
The effect of interferon-beta on black holes in patients with multiple sclerosis
Francesca Bagnato1, Iordanis E Evangelou, Antonio Gallo
1National Institute of Health, National Institute for Neurological Diseases and Stroke, Neuroimmunology Branch, Bethesda, MD 20892-1400, USA. bagnatof@ninds.nih.gov
Abstract:
Multiple sclerosis (MS) is an immunological disorder of the CNS. Linked to an initial transient inflammation as the result of blood-brain barrier leakage, the disease progresses into a neurodegenerative phase. MRI is the most powerful paraclinical tool for diagnosing and monitoring MS. Although contrast enhancing lesions are the visible events of blood-brain barrier breakdown, accumulation of hypointense lesions, namely black holes, are recognised as irreversible axonal loss. IFN-beta is administered as a first-line drug in MS patients. However, whether the effect of IFN-beta extends beyond just prevention of blood-brain barrier leakage and further prevents the formation of black holes or promotes their recovery once formed, is not yet understood.
Insights
Multiple sclerosis involves CNS inflammation and neurodegeneration. This study investigates if interferon-beta (IFN-beta) treatment prevents irreversible axonal loss, known as black holes, in multiple sclerosis patients.
Area of Science:
- Neuroimmunology
- Central Nervous System (CNS) Disorders
- Neurodegenerative Diseases
Background:
- Multiple sclerosis (MS) is an immunological CNS disorder characterized by initial inflammation and subsequent neurodegeneration.
- Magnetic Resonance Imaging (MRI) is crucial for MS diagnosis and monitoring, identifying contrast-enhancing lesions (blood-brain barrier leakage) and black holes (irreversible axonal loss).
- Interferon-beta (IFN-beta) is a standard first-line treatment for MS, primarily targeting inflammation.
Purpose of the Study:
- To determine if IFN-beta treatment impacts the formation or recovery of black holes in MS patients.
- To investigate the neuroprotective effects of IFN-beta beyond its anti-inflammatory actions.
Main Methods:
- This study focuses on analyzing the known effects of IFN-beta on MS pathology.
- Utilizing MRI data to assess lesion evolution and the presence of black holes in patients undergoing IFN-beta therapy.
Main Results:
- The current understanding suggests IFN-beta's primary role is in managing blood-brain barrier leakage.
- Evidence regarding IFN-beta's direct effect on preventing or reversing black hole formation remains inconclusive.
Conclusions:
- Further research is needed to elucidate the full impact of IFN-beta on neurodegeneration in MS.
- Understanding IFN-beta's role in black hole pathology could refine treatment strategies for multiple sclerosis.
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Multiple Sclerosis l: Introduction
Detection of Black Holes
Their closest cousins are neutron stars, which are composed almost entirely of neutrons packed against each other, making them extremely dense. A neutron star has the same mass as the Sun but its diameter is only a few kilometers. Therefore, the escape velocity from their surface is close to the speed of light.
Not until the 1960s, when the first neutron...